Conavi Medical Corp.
CNVI.V
TSX
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Net Income | -21.54M | -28.48M | -30.32M | -32.02M | -25.49M |
| Total Depreciation and Amortization | 556.70K | 585.20K | 649.60K | 708.90K | 696.70K |
| Total Amortization of Deferred Charges | 55.30K | 42.30K | 29.80K | 16.90K | 87.20K |
| Total Other Non-Cash Items | 4.54M | 8.23M | 10.77M | 13.32M | 5.79M |
| Change in Net Operating Assets | -1.21M | 3.63M | 3.40M | 3.17M | 3.41M |
| Cash from Operations | -17.60M | -15.99M | -15.47M | -14.81M | -15.50M |
| Capital Expenditure | -160.40K | -235.00K | -330.10K | -423.70K | -421.90K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 2.60M | 2.57M | 1.20M | -201.10K | -197.90K |
| Cash from Investing | 2.44M | 2.34M | 872.40K | -624.70K | -619.80K |
| Total Debt Issued | 3.53M | 8.19M | 8.19M | 8.19M | 5.07M |
| Total Debt Repaid | -1.40M | -1.20M | -1.07M | -937.00K | -1.11M |
| Issuance of Common Stock | 22.20M | 10.09M | 5.05M | 6.00K | 7.00K |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | 16.52M |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 6.33M | -- | -- | -- | -- |
| Cash from Financing | 22.03M | 12.26M | 8.83M | 5.31M | 15.21M |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 6.87M | -1.39M | -5.77M | -10.12M | -907.80K |